https://pubmed.ncbi.nlm.nih.gov/37227925/
TBI and TBD incidence continued through 1 year in rifampin-/multidrug-resistant TB HHCs. Low TPT coverage emphasizes the need for evidence-based prevention and...
yearincidencetuberculosisinfectiondisease
https://www.aidsmap.com/news/aug-2005/ias-rifampin-tb-treatment-does-not-reduce-response-nnrtis-south-africans-report
Using rifampin-based therapy alongside a triple antiretroviral regimen that contains drugs from the NNRTI class (either nevirapine or efavirenz) does not...
tb treatmentiasrifampinreduceresponse